Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 1, 2006

Biofusion to Commercialize all Cardiff University IP

  • The University of Cardiff gained a £17-million equity stake in Biofusion, in return for exclusive rights for 10 years to commercialize 100% of all Cardiff University research-generated IP.

    The company claims the agreement will allow Cardiff University to triple its research spending, to some £1 billion over the 10 years. Through the life of the deal Biofusion will also take over Cardiff University’s shares in seven existing spin-out companies and will have 100% ownership of all future Cardiff University spin-outs.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »